Authors: Gustafsson, D Nystrom, JE Carlsson, S Bredberg, U Eriksson, U Gyzander, E Elg, M Antonsson, T Hoffmann, KJ Ungell, AL Sorensen, H Nagard, S Abrahamsson, A Bylund, R

Citation: D. Gustafsson et al., The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: Intestinal absorption properties, biochemical and pharmacodynamic effects, THROMB RES, 101(3), 2001, pp. 171-181

Authors: Karlsson, J Ungell, AL Grasjo, J Artursson, P

Citation: J. Karlsson et al., Paracellular drug transport across intestinal epithelia: influence of charge and induced water flux, EUR J PH SC, 9(1), 1999, pp. 47-56

Authors: Sjostrom, M Lindfors, L Ungell, AL

Citation: M. Sjostrom et al., Inhibition of binding of an enzymatically stable thrombin inhibitor to lumenal proteases as an additional mechanism of intestinal absorption enhancement, PHARM RES, 16(1), 1999, pp. 74-79

Authors: Lindahl, A Persson, B Ungell, AL Lennernas, H

Citation: A. Lindahl et al., Surface activity and concentration dependent intestinal permeability in the rat, PHARM RES, 16(1), 1999, pp. 97-102

Authors: Lindahl, A Sandstrom, R Ungell, AL Lennernas, H

Citation: A. Lindahl et al., Concentration- and region-dependent intestinal permeability of fluvastatinin the rat, J PHARM PHA, 50(7), 1998, pp. 737-744

Authors: Palm, K Luthman, K Ungell, AL Strandlund, G Beigi, F Lundahl, P Artursson, P

Citation: K. Palm et al., Evaluation of dynamic polar molecular surface area as predictor of drug absorption: Comparison with other computational and experimental predictors, J MED CHEM, 41(27), 1998, pp. 5382-5392